{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:07:11Z","timestamp":1778638031033,"version":"3.51.4"},"reference-count":47,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T00:00:00Z","timestamp":1570233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006952","name":"Louisiana Board of Regents","doi-asserted-by":"publisher","award":["LEQSF (2017-20)-RD-B-07"],"award-info":[{"award-number":["LEQSF (2017-20)-RD-B-07"]}],"id":[{"id":"10.13039\/100006952","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>S-(\u2013)-Oleocanthal (OC), a naturally occurring phenolic secoiridoid exclusively found in extra-virgin olive oil (EVOO), is a potential nutraceutical therapeutic for inflammation, neurodegenerative diseases, and many malignancies, especially breast cancer (BC). The oral delivery of OC is challenging because of its irritative, bitter, and pungent taste and exceptional chemistry, including two reactive aldehydes, phenolic, and ester groups. OC irritation did not correlate with CO2-induced irritation, and hence, OC was not exerting generalized acid-sensing irritation. The objective of this study was to develop an effervescent formulation of OC with an effective CO2-induced masked taste maintaining the efficacy against the estrogen receptor (ER) and HER2 positive BC. Several ratios of acid and carbonate sources were screened, and five effervescent formulations EF1-EF5 were selected and prepared based on their pH and effervescence time. OC formulations were characterized using differential scanning calorimetry, FT-IR spectroscopy, and scanning electron microscopy analyses. OC formulations exhibited acceptable flowability and effervescence time. Based on physical characteristics and improved OC release, formulation EF-2 was selected for subsequent studies. EF-2 showed effective OC taste masking, as suggested by electronic artificial tongue and mouse preference tests. EF-2 suppressed more than 70% of the hormone and HER2-positive BT-474 BC cell growth in a nude mouse xenograft model. Furthermore, EF-2 demonstrated significant inhibition of BT-474 tumor cell locoregional recurrence after primary tumor surgical excision. EF-2-treated mouse sera had significantly reduced CA 15-3 levels, the human BC recurrence marker, compared to the placebo control group at the end of the study. These results highlight the potential of the OC formulation EF-2 as a prospective nutraceutical for the control and prevention of ER+\/HER+ BC progression and locoregional recurrence.<\/jats:p>","DOI":"10.3390\/pharmaceutics11100515","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T03:34:01Z","timestamp":1570419241000},"page":"515","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Optimization of Taste-Masked (\u2013)-Oleocanthal Effervescent Formulation with Potent Breast Cancer Progression and Recurrence Suppressive Activities"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4717-1141","authenticated-orcid":false,"given":"Afsana","family":"Tajmim","sequence":"first","affiliation":[{"name":"School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, Louisiana 71209, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5424-9475","authenticated-orcid":false,"given":"Abu Bakar","family":"Siddique","sequence":"additional","affiliation":[{"name":"School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, Louisiana 71209, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1456-4064","authenticated-orcid":false,"given":"Khalid","family":"El Sayed","sequence":"additional","affiliation":[{"name":"School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, Louisiana 71209, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,10,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Pang, K.L., and Chin, K.Y. (2018). The biological activities of oleocanthal from a molecular perspective. Nutrients, 10.","DOI":"10.3390\/nu10050570"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"12323","DOI":"10.3390\/ijms150712323","article-title":"Oleocanthal, a phenolic derived from virgin olive oil: A review of the beneficial effects on inflammatory disease","volume":"15","author":"Parkinson","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3390\/ijms11020458","article-title":"Biological activities of phenolic compounds present in virgin olive oil","volume":"11","author":"Cicerale","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.copbio.2011.09.006","article-title":"Antimicrobial, antioxidant and anti-inflammatory phenolic activities in extra virgin olive oil","volume":"23","author":"Cicerale","year":"2012","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Segura-Carretero, A., and Curiel, J.A. (2018). Current disease-targets for oleocanthal as promising natural therapeutic agent. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19102899"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1021\/jf026042j","article-title":"Sensory properties of virgin olive oil polyphenols: Identification of deacetoxy-ligstroside aglycon as a key contributor to pungency","volume":"51","author":"Andrewes","year":"2003","journal-title":"J. Agric Food Chem."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Akl, M.R., Ayoub, N.M., Mohyeldin, M.M., Busnena, B.A., Foudah, A.I., Liu, Y.Y., and Sayed, K.A. (2014). Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0097622"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1021\/jf00021a019","article-title":"Simple and hydrolyzable phenolic compounds in virgin olive oil. 1. Their extraction, separation, and quantitative and semiquantitative evaluation by HPLC","volume":"40","author":"Montedoro","year":"1992","journal-title":"J. Agric. Food Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1021\/jf00035a076","article-title":"Simple and hydrolyzable compounds in virgin olive oil. 3. Spectroscopic characterizations of the secoiridoid derivatives","volume":"41","author":"Montedoro","year":"1993","journal-title":"J. Agric. Food Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/437045a","article-title":"Phytochemistry: Ibuprofen-like activity in extra-virgin olive oil","volume":"437","author":"Beauchamp","year":"2005","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.lfs.2012.09.012","article-title":"Further evidence for the anti-inflammatory activity of oleocanthal: Inhibition of MIP-1\u03b1 and IL-6 in J774 macrophages and in ATDC5 chondrocytes","volume":"91","author":"Scotece","year":"2012","journal-title":"Life Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1523\/JNEUROSCI.1374-10.2011","article-title":"Unusual pungency from extra-virgin olive oil is attributable to restricted spatial expression of the receptor of oleocanthal","volume":"31","author":"Uchida","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/chemse\/bjp006","article-title":"Sensory characterization of the irritant properties of oleocanthal, a natural anti-inflammatory agent in extra-virgin olive oils","volume":"34","author":"Cicerale","year":"2009","journal-title":"Chem. Senses"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neuroscience.2017.03.059","article-title":"Oleocanthal ameliorates amyloid-beta oligomers\u2019 toxicity on astrocytes and neuronal cells: In vitro studies","volume":"352","author":"Batarseh","year":"2017","journal-title":"Neuroscience"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1021\/acschemneuro.5b00190","article-title":"Oleocanthal enhances amyloid-beta clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model","volume":"6","author":"Qosa","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1021\/np300384h","article-title":"Modulation of tau protein fibrillization by oleocanthal","volume":"75","author":"Monti","year":"2012","journal-title":"J. Nat. Prod."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.taap.2009.07.018","article-title":"Alzheimer\u2019s-associated Abeta oligomers show altered structure; immunoreactivity and synaptotoxicity with low doses of oleocanthal","volume":"240","author":"Pitt","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"43475","DOI":"10.18632\/oncotarget.9782","article-title":"(-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma","volume":"7","author":"Pei","year":"2016","journal-title":"Oncotarget"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1055\/s-0030-1270724","article-title":"(-)-Oleocanthal as a c-Met inhibitor for the control of metastatic breast and prostate cancers","volume":"77","author":"Elnagar","year":"2011","journal-title":"Planta Med."},{"key":"ref_20","first-page":"46","article-title":"Potential role of signal transducer and activator of transcription 3 (STAT3) signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma","volume":"1835","author":"Subramaniam","year":"2013","journal-title":"Biochim Biophys. Acta."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.tiv.2018.06.021","article-title":"Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer","volume":"52","author":"Polini","year":"2018","journal-title":"Toxicol. In Vitro."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e1006077","DOI":"10.1080\/23723556.2015.1006077","article-title":"(-)-Oleocanthal rapidly and selectively induces cancer cell death via lysosomal membrane permeabilization","volume":"2","author":"LeGendre","year":"2015","journal-title":"Mol. Cell Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejphar.2017.06.019","article-title":"The olive oil phenolic (-)-oleocanthal modulates estrogen receptor expression in luminal breast cancer in vitro and in vivo and synergizes with tamoxifen treatment","volume":"810","author":"Ayoub","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"ref_24","unstructured":"Padmanabhan, B., Shetty, R., Kulkarni, V., Sen, H., and Bhushan, I. (2014). Effervescent Composition and Method of Making it. (WO2016042372A1), WIPO (PCT), Available online: https:\/\/patents.google.com\/patent\/WO2016042372A1."},{"key":"ref_25","unstructured":"Parikh, M.D. (2005). Effervescent powder. Hand Book of Pharmaceutical Granulation Technology, Taylor & Francis Group. [2nd ed.]. Available online: http:\/\/www.gmpua.com\/Process\/Tablet\/Granulation\/GranulationTechnology.pdf."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Siddique, A.B., Ebrahim, H.E., Qusa, M., Btarsah, Y., Fayaad, A., Tajmim, A., Nazzal, S., Kaddoumi, A., and El Sayed, K.A. (2019). Novel liquid-liquid extraction and self-emulsion methods for simplified isolation of extra-virgin olive oil phenolics with emphasis on (-)-oleocanthal and its oral anti-breast cancer activity. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0214798"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/03639040802337021","article-title":"Preparation and evaluation of fast-disintegrating effervescent tablets of glibenclamide","volume":"35","author":"Jacob","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.2042-7158.1958.tb10391.x","article-title":"Some aspects of the property of angle of repose of powders","volume":"10","author":"Train","year":"1958","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1208\/s12249-014-0239-z","article-title":"Masking the bitter taste of injectable lidocaine HCl formulation for dental procedures","volume":"16","author":"Wei","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Podrazka, M., Baczynska, E., Kundys, M., Jelen, P.S., and Nery, E.W. (2018). Electronic tongue-A tool for all tastes?. Biosensors, 8.","DOI":"10.3390\/bios8010003"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/00952990.2014.990091","article-title":"Bitter taste and nicotine preference: Evidence for sex differences in rats","volume":"41","author":"Nesil","year":"2005","journal-title":"Am. J. Drug Alcohol Ab."},{"key":"ref_32","unstructured":"Weidner, J. (2013, May 01). Cell viability assays, Assay Guidance Manual, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK144065\/."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Siddique, A.B., Ayoub, N.M., Tajmim, A., Meyer, S.A., Hill, R.A., and El Sayed, K.A. (2019). (-)-Oleocanthal prevents breast cancer locoregional recurrence after primary tumor surgical excision and neoadjuvant targeted therapy in orthotopic nude mouse models. Cancers, 11.","DOI":"10.3390\/cancers11050637"},{"key":"ref_34","first-page":"217","article-title":"Formulation, characterization and physicochemical evaluation of potassium citrate effervescent tablets","volume":"3","author":"Aslani","year":"2013","journal-title":"Adv. Pharm. Bull."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Zhou, H., Wan, J., Wu, L., Yi, T., Liu, W., Xu, H., and Yang, X. (2013). A new strategy for enhancing the oral bioavailability of drugs with poor water-solubility and low liposolubility based on phospholipid complex and supersaturated SEDDS. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0084530"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1166\/sl.2006.055","article-title":"Correlation between human panel and electronic tongue responses on the analysis of commercial sweeteners","volume":"4","author":"Dyminski","year":"2006","journal-title":"Sens. Lett."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Zhang, X., Zhang, Y., Meng, Q., Li, N., and Ren, L. (2015). Evaluation of beef by electronic tongue system TS-5000Z: Flavor assessment, recognition and chemical compositions according to its correlation with flavor. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0137807"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/bcr2889","article-title":"Choosing the right cell line for breast cancer research","volume":"13","author":"Holliday","year":"2011","journal-title":"Breast Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Siddique, A., Ibrahim, H.Y., Akl, M.R., Ayoub, N.M., Goda, A.A., Mohyeldin, M.M., Nagumalli, S.K., Hananeh, W.M., Liu, Y.Y., and Meyer, S.A. (2019). (-)-Oleocanthal combined with lapatinib treatment synergized against HER-2 positive breast cancer in vitro and in vivo. Nutrients, 11.","DOI":"10.3390\/nu11020412"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Ahmad, A. (2013). Pathways to breast cancer recurrence. ISRN Oncol., 2013.","DOI":"10.1155\/2013\/290568"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.7314\/APJCP.2014.15.14.5539","article-title":"Breast cancer recurrence according to molecular subtype","volume":"15","author":"Shim","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13058-015-0547-6","article-title":"The clinical and functional significance of c-Met in breast cancer: A review","volume":"17","author":"Jones","year":"2015","journal-title":"Breast Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/cncr.28386","article-title":"c-Met in invasive breast cancer. Is there a relationship with the basal-like subtype?","volume":"120","author":"Green","year":"2014","journal-title":"Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.3747\/co.19.974","article-title":"Excision of the primary tumor in patients with metastatic breast cancer: A clinical dilemma","volume":"19","author":"Samiee","year":"2012","journal-title":"Curr. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.1158\/1078-0432.CCR-13-2158","article-title":"The cancer diaspora: Metastasis beyond the seed and soil hypothesis","volume":"19","author":"Pienta","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrclinonc.2011.64","article-title":"Clinical implications of cancer self-seeding","volume":"8","author":"Comen","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: Relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/11\/10\/515\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:27:48Z","timestamp":1760189268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/11\/10\/515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,5]]},"references-count":47,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["pharmaceutics11100515"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics11100515","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,5]]}}}